Radical Cystectomy for Recurrent Urothelial Carcinoma After Prior Partial Cystectomy: Perioperative and Oncologic Outcomes

Overview

Journal World J Urol

Specialty Urology

Date 2017 Sep 16

PMID 28913657

Authors

Ross J Mason

Igor Frank

Bimal Bhindi

Matthew K Tollefson

R Houston Thompson

R Jeffrey Karnes

Robert Tarrell

Prabin Thapa

Stephen A Boorjian

Affiliations

Soon will be listed here.

Abstract

Purpose: To evaluate perioperative and oncologic outcomes of patients undergoing radical cystectomy (RC) for recurrence of urothelial carcinoma (UC) after prior partial cystectomy (PC), and to compare these outcomes to patients undergoing primary RC.

Methods: Patients who underwent RC for recurrence of UC after prior PC were matched 1:3 to patients undergoing primary RC based on age, pathologic stage, and decade of surgery. Perioperative and oncologic outcomes were compared using Wilcoxon sign-rank test, McNemars test, the Kaplan-Meier method, and Cox proportional hazards regression analyses.

Results: Overall, the cohorts were well matched on clinical and pathological characteristics. No difference was noted in operative time (median 322 versus 303 min; p = 0.41), estimated blood loss (median 800 versus 700 cc, p = 0.10) or length of stay (median 9 versus 10 days; p = 0.09). Similarly, there were no differences in minor (51.7 versus 44.3%; p = 0.32) or major (10.3 versus 12.6%; p = 0.66) perioperative complications. Median follow-up after RC was 5.0 years (IQR 1.5, 13.1 years). Notably, CSS was significantly worse for patients who underwent RC after PC (10 year-46.8 versus 65.9%; p = 0.03). On multivariable analysis, prior PC remained independently associated with an increased risk of bladder cancer death (HR 2.28; 95% CI 1.17, 4.42).

Conclusions: RC after PC is feasible, without significantly adverse perioperative outcomes compared to patients undergoing primary RC. However, the risk of death from bladder cancer may be higher, suggesting the need for careful patient counseling prior to PC and the consideration of such patients for adjuvant therapy after RC.

References

Lavallee L, Schramm D, Witiuk K, Mallick R, Fergusson D, Morash C . Peri-operative morbidity associated with radical cystectomy in a multicenter database of community and academic hospitals. PLoS One. 2014; 9(10):e111281. PMC: 4216067. DOI: 10.1371/journal.pone.0111281. View

Schoborg T, Sapolsky J, LEWIS Jr C . Carcinoma of the bladder treated by segmental resection. J Urol. 1979; 122(4):473-5. DOI: 10.1016/s0022-5347(17)56469-1. View

Schrier B, Hollander M, van Rhijn B, Kiemeney L, Witjes J . Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur Urol. 2004; 45(3):292-6. DOI: 10.1016/j.eururo.2003.10.006. View

Novick A, STEWART B . Partial cystectomy in the treatment of primary and secondary carcinoma of the bladder. J Urol. 1976; 116(5):570-4. DOI: 10.1016/s0022-5347(17)58915-6. View

Kassouf W, Swanson D, Kamat A, Leibovici D, Siefker-Radtke A, Munsell M . Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience. J Urol. 2006; 175(6):2058-62. DOI: 10.1016/S0022-5347(06)00322-3. View

Holzbeierlein J, Lopez-Corona E, Bochner B, Herr H, Donat S, Russo P . Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection. J Urol. 2004; 172(3):878-81. DOI: 10.1097/01.ju.0000135530.59860.7d. View

Gray P, Fedewa S, Shipley W, Efstathiou J, Lin C, Zietman A . Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base. Eur Urol. 2012; 63(5):823-9. DOI: 10.1016/j.eururo.2012.11.015. View

Fahmy N, Aprikian A, Tanguay S, Mahmud S, Al-Otaibi M, Jeyaganth S . Practice patterns and recurrence after partial cystectomy for bladder cancer. World J Urol. 2009; 28(4):419-23. DOI: 10.1007/s00345-009-0478-x. View

Resnick M, OCONOR Jr V . Segmental resection for carcinoma of the bladder: review of 102 patients. J Urol. 1973; 109(6):1007-10. DOI: 10.1016/s0022-5347(17)60608-6. View

10.

Fedeli U, Fedewa S, Ward E . Treatment of muscle invasive bladder cancer: evidence from the National Cancer Database, 2003 to 2007. J Urol. 2010; 185(1):72-8. DOI: 10.1016/j.juro.2010.09.015. View

11.

Faiena I, Dombrovskiy V, Koprowski C, Singer E, Jang T, Weiss R . Performance of partial cystectomy in the United States from 2001 to 2010: trends and comparative outcomes. Can J Urol. 2014; 21(6):7520-7. PMC: 4297651. View

12.

Kates M, Gorin M, Deibert C, Pierorazio P, Schoenberg M, McKiernan J . In-hospital death and hospital-acquired complications among patients undergoing partial cystectomy for bladder cancer in the United States. Urol Oncol. 2013; 32(1):53.e9-14. DOI: 10.1016/j.urolonc.2013.08.024. View

13.

Dindo D, Demartines N, Clavien P . Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240(2):205-13. PMC: 1360123. DOI: 10.1097/01.sla.0000133083.54934.ae. View

14.

Smaldone M, Jacobs B, Smaldone A, Hrebinko Jr R . Long-term results of selective partial cystectomy for invasive urothelial bladder carcinoma. Urology. 2008; 72(3):613-6. DOI: 10.1016/j.urology.2008.04.052. View

15.

van den Bosch S, Witjes J . Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review. Eur Urol. 2011; 60(3):493-500. DOI: 10.1016/j.eururo.2011.05.045. View

16.

Bruins H, Wopat R, Mitra A, Cai J, Miranda G, Skinner E . Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy. BJU Int. 2012; 111(3 Pt B):E37-42. DOI: 10.1111/j.1464-410X.2012.11438.x. View

17.

Breau R, Karnes R, Farmer S, Thapa P, Cagiannos I, Morash C . Progression to detrusor muscle invasion during urothelial carcinoma surveillance is associated with poor prognosis. BJU Int. 2013; 113(6):900-6. DOI: 10.1111/bju.12403. View

18.

Shabsigh A, Korets R, Vora K, Brooks C, Cronin A, Savage C . Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2008; 55(1):164-74. DOI: 10.1016/j.eururo.2008.07.031. View

19.

Knoedler J, Boorjian S, Kim S, Weight C, Thapa P, Tarrell R . Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis. J Urol. 2012; 188(4):1115-9. DOI: 10.1016/j.juro.2012.06.029. View

20.

Marshall V, Holden J, Ma K . Survival of patients with bladder carcinoma treated by simple segmental resection; one hundred twenty-three consecutive cases five years later. Cancer. 1956; 9(3):568-71. DOI: 10.1002/1097-0142(195605/06)9:3<568::aid-cncr2820090322>3.0.co;2-0. View